STOCK TITAN

Medicare Annual Enrollment Halftime Report: 75% of enrollees have used AI tools to review 2027 Medicare plans

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
AI

eHealth (EHTH) published a mid-enrollment report on how Medicare beneficiaries reviewed their 2027 plan options and what those plans offered. Among beneficiaries who reviewed their options, 75% used AI tools to help. When selecting a plan, 50% said they relied most on a licensed insurance agent, versus 4% who cited AI. Separately, 63% of Medicare beneficiaries reported being surprised by high monthly premiums for 2027 plans.

Among Medicare Advantage plans eHealth offered for 2027, 93% covered at least one GLP-1 drug for obesity when qualifying conditions were met, up from 5% in 2026. The share offering a Part B premium refund fell to 20% from 32%. For plans eHealth customers selected, the average out-of-pocket maximum rose 8%, from $6,225 for 2026 plans to $6,703 for 2027 plans.

Loading...
Loading translation...

Key Figures

Beneficiaries using AI tools: 75% Plans covering a GLP-1 drug for obesity: 93% (vs. 5%) Plans with a Part B premium refund: 20% (vs. 32%) +1 more
Beneficiaries using AI tools
75%
Among Medicare beneficiaries who reviewed their 2027 plan options
Plans covering a GLP-1 drug for obesity
93% (vs. 5%)
eHealth Medicare Advantage plans; 2027 vs. 2026
Plans with a Part B premium refund
20% (vs. 32%)
eHealth Medicare Advantage plans; 2027 vs. 2026
Average out-of-pocket maximum
8% increase; $6,225 to $6,703
Plans selected by eHealth customers; 2026 to 2027

Key Terms

glp-1, medicare advantage, annual enrollment period, out-of-pocket maximum
4 terms
glp-1 medical
"include coverage of a GLP-1 drug to treat obesity"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.
medicare advantage regulatory
"93% of 2027 Medicare Advantage plans offered by eHealth"
Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.
annual enrollment period regulatory
"Medicare's Annual Enrollment Period (AEP) past the halfway point"
A yearly window when individuals covered by certain health insurance programs can enroll in, cancel, or switch plans and make coverage choices for the coming year. Think of it like a seasonal shopping period for health coverage: the choices people make during this brief time determine insurers’ customer counts and revenue for the next year, so shifts in enrollment can materially affect insurance companies’ financial results and investor expectations.
out-of-pocket maximum financial
"increase in the average out-of-pocket maximum for plans selected by eHealth customers"
The out-of-pocket maximum is the most a person will pay in a year for covered medical care, after which their insurer pays 100% of further covered costs; think of it as a financial ceiling on your health bills. For investors, it matters because this cap influences employee disposable income, corporate benefit expenses and how much risk insurers or employers carry for large medical claims, affecting profits and cash flow.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

60% of Americans are more optimistic about healthcare access and affordability following the mid-term elections, including three-quarters of Medicare beneficiaries

63% of Medicare beneficiaries report being surprised by high monthly premiums for 2027 plans, amid rising costs for plan deductibles and out-of-pocket maximums

93% of 2027 Medicare Advantage plans offered by eHealth now include coverage of at least one GLP-1 drug for obesity, up significantly compared to 2026 plans

INDIANAPOLIS, Nov. 19, 2026 /PRNewswire/ -- With this year's Medicare's Annual Enrollment Period (AEP) past the halfway point, new eHealth (Nasdaq: EHTH) research reveals growing use of artificial intelligence (AI) to compare options, which includes many Medicare Advantage plans that now include coverage of a GLP-1 drug to treat obesity, when qualifying conditions are met.

Medicare Annual Enrollment Halftime Report

Based on the survey of over 1,000 Americans and proprietary data from eHealth, a leading private online health insurance marketplace, the new report found:

  • 75% of Medicare beneficiaries who have reviewed their 2027 plan options used AI tools to help them do so.
  • 50% of Medicare beneficiaries who reviewed their 2027 options say they relied most on a licensed insurance agent when selecting a plan, followed by an insurance comparison website (14%), government resources (7%) and AI tools (4%).
  • 60% of Americans are more optimistic about healthcare access and affordability following the mid-term elections, including 76% of Medicare beneficiaries. 
  • 42% of Americans say lowering the total cost of care should be the #1 priority for Congress next year, while 25% cite expanding access to health insurance.
  • 93% of 2027 Medicare Advantage plans offered by eHealth include coverage of at least one GLP-1 drug for treatment of obesity when qualifying conditions are met, compared to 5% of plans in 2026.

"Halfway through this fall's Medicare Annual Enrollment Period, a growing number of beneficiaries are turning to technology to help navigate one of the most complex and consequential decisions they will make this year," said Derrick Duke, CEO of eHealth. "While many people are pleased with their Medicare options for 2027, cost is still a concern, given the increase in out-of-pocket maximums. With millions of Medicare beneficiaries still to make crucial plan decisions during the final weeks of this year's enrollment cycle, it is important enrollees and their families effectively compare their options to help make informed decisions based on their specific situations, needs, and budgets."

Additional highlights from the report:

On beneficiaries' experience and priorities this AEP

  • 92% of Medicare beneficiaries who have reviewed their 2027 plan options express satisfaction with their choices.
  • 69% of Medicare beneficiaries say getting coverage for GLP-1 drugs is "important" when selecting a new plan. 
  • 69% of Medicare Advantage enrollees say they will have to change doctors or medical facilities in 2027, due to plan changes.
  • 93% of Medicare Advantage enrollees consider getting a Part B premium reduction benefit "important" when selecting a new plan.
  • 63% of Medicare beneficiaries were surprised by high monthly premiums for 2027 plans, while 16% were surprised by other out-of-pocket costs.

On proposals to expand Medicare eligibility and benefits

  • 63% of Americans favor lowering Medicare's standard eligibility age from 65 to 55, even if it means increased federal payroll taxes or reduced benefits for existing beneficiaries.
  • 81% of Americans favor adding dental, vision, and hearing benefits to Original Medicare, even if it means increasing payroll taxes and reducing other benefits for existing beneficiaries.

On Medicare Advantage plans offered by eHealth and selected so far during AEP

  • 20% of 2027 Medicare Advantage plans offered by eHealth include a Part B premium refund, down significantly compared to 32% of plans in 2026.
  • 8% increase in the average out-of-pocket maximum for plans selected by eHealth customers, rising from $6,225 for 2026 plans to $6,703 for 2027 plans.

Read the full report.

eHealth's report is based on a nationwide, census-balanced survey of more than 1,000 Americans drawn from the general population. The survey was conducted in November 2026 through a third-party survey tool. The overall margin of error is +/- 3%. Plan benefit, cost, and selection data are based on 2027 Medicare plans available through eHealth or on Medicare plans selected by eHealth customers in the period from October 15 through November 8, 2026. eHealth does not offer all Medicare plans available in every market.

About eHealth
For nearly 30 years, eHealth, Inc. (Nasdaq: EHTH) has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford, using data, artificial intelligence and a consumer-first approach to help people quickly and effectively compare insurance options. As a leading independent licensed insurance agency and advisor, eHealth offers access to plans from more than 180 health insurers, including national and regional companies, supporting consumers during their working years and retirement. eHealth's licensed insurance agents help match consumers with the insurance plans, services, and support they need to live healthier, more financially secure lives. For more information, visit eHealth or follow us on LinkedIn, Facebook, Instagram, and X.

eHealth media inquiries: pr@ehealth.com

eHealth, Inc.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medicare-annual-enrollment-halftime-report-75-of-enrollees-have-used-ai-tools-to-review-2027-medicare-plans-302944835.html

SOURCE eHealth, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Medicare beneficiaries used AI to review 2027 plans in eHealth’s enrollment report?

75% of Medicare beneficiaries who reviewed their 2027 plan options used AI tools to help with that review.

How many Medicare Advantage plans offered by eHealth cover GLP-1 drugs for obesity in 2027?

93% of the 2027 Medicare Advantage plans offered by eHealth cover at least one GLP-1 drug for obesity when qualifying conditions are met, compared with 5% of its 2026 plans.

How did eHealth collect the data for its Medicare enrollment report?

eHealth combined a nationwide, census-balanced survey of more than 1,000 Americans with its own plan data. The November 2026 survey had an overall margin of error of +/- 3%. Plan data came from 2027 Medicare plans available through eHealth or Medicare plans selected by its customers from October 15 through November 8, 2026.

Keep reading